Timothy J T Chevassut (Tim Chevassut, Timothy Chevassut)

Publication Activity (10 Years)

Years Active: 2014-2022
Publications (10 Years): 9

Top Topics

Acute Myeloid Leukemia

Combination Therapy

Embryonic Stem Cells

Top Venues

British journal of haematology

Bone marrow research

European journal of haematology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

David Antony Palmer, Lauren Davis, Helena Sivaloganathan, Timothy J T Chevassut
A Single-Centre Experience of Post-COVID-19 Vaccine-Related Immune-Mediated Complications. Case reports in hematology 2022 (2022)
Samuel Olaitan, Megan Wagstaff, Okan Sevim, Raquel Akieme, Valentina Toska, Caroline Humphreys, Lorraine Shah-Goodwin, John Bell, Timothy J T Chevassut, Rhys G Morgan
Assessment of mononuclear cell populations derived from human umbilical cord blood. European journal of haematology 109 (6) (2022)
Anne-Louise Latif, Ashley Newcombe, Sha Li, Kathryn Gilroy, Neil Alistair Robertson, Xue Lei, Helen J S Stewart, John Cole, Maria Terradas Terradas, Loveena Rishi, Lynn McGarry, Claire McKeeve, Claire Reid, William Clark, Joana Campos, Kristina Kirschner, Andrew Davis, Jonathan Lopez, Jun-Ichi Sakamaki, Jennifer P Morton, Kevin M Ryan, Stephen W G Tait, Sheela A Abraham, Tessa Holyoake, Brian Higgins, Xu Huang, Karen Blyth, Mhairi Copland, Timothy J T Chevassut, Karen Keeshan, Peter D Adams
BRD4-mediated repression of p53 is a target for combination therapy in AML. Nature communications 12 (1) (2021)
Emma Kennedy, Eve Coulter, Emma Halliwell, Núria Profitós-Pelejà, Elisabeth Walsby, Barnaby Clark, Elizabeth H Phillips, Thomas A Burley, Christopher Iain Jones, Stephen Devereux, Christopher D Fegan, Rosalynd Johnston, Timothy J T Chevassut, Ralph Schulz, Martina Seiffert, Angelo Agathanggelou, Ceri E Oldreive, Nicholas Davies, Tatjana Stankovic, Triantafillos Liloglou, Christopher J Pepper, Andrea G S Buggins
TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target. Blood 137 (22) (2021)
Rupert Phillips, Henry Wood, Gary Weaving, Timothy J T Chevassut
Changes in full blood count parameters with age and sex: results of a survey of almost 900 000 patient samples from primary care. British journal of haematology 192 (4) (2021)
Helena Sivaloganathan, Eleni E Ladikou, Timothy J T Chevassut
COVID-19 mortality in patients on anticoagulants and antiplatelet agents. British journal of haematology 190 (4) (2020)
Eleni E Ladikou, Timothy J T Chevassut, Christopher J Pepper, Andrea G S Buggins
Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia. British journal of haematology 189 (5) (2020)
Helen J S Stewart, Sabah Chaudry, Asante Crichlow, Freya Luiling Feilding, Timothy J T Chevassut
BET Inhibition Suppresses S100A8 and S100A9 Expression in Acute Myeloid Leukemia Cells and Synergises with Daunorubicin in Causing Cell Death. Bone marrow research 2018 (2018)
Sabah F Chaudry, Timothy J T Chevassut
Epigenetic Guardian: A Review of the DNA Methyltransferase DNMT3A in Acute Myeloid Leukaemia and Clonal Haematopoiesis. BioMed research international 2017 (2017)
Louis Norman, Paul Tarrant, Timothy J T Chevassut
TET2 Inhibits Differentiation of Embryonic Stem Cells but Does Not Overcome Methylation-Induced Gene Silencing. Bone marrow research 2014 (2014)
Emma Conway O'Brien, Steven Prideaux, Timothy J T Chevassut
The epigenetic landscape of acute myeloid leukemia. Advances in hematology 2014 (2014)